Alcon, the eyecare business of Novartis, posted a 3 percent sales increase for the third quarter, with growth of 5 percent in constant currencies. The Surgical business' increase of 7 percent in constant currencies was driven by double-digit growth for the company's advanced intraocular lenses, as well as continued growth ...
Buying a membership today will give you:
To continue reading this article register now.